Amneal Pharmaceuticals (AMRX)
(Delayed Data from NSDQ)
$5.90 USD
-0.15 (-2.48%)
Updated Apr 25, 2024 04:00 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/3/24 |
---|---|
Current Quarter | 0.09 |
EPS Last Quarter | 0.14 |
Last EPS Surprise | 100.00% |
ABR | 1.80 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.57 |
Next Year | 0.63 |
EPS (TTM) | 0.64 |
P/E (F1) | 10.35 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 621.86M | 648.93M | 2.60B | 2.73B |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 631.33M | 654.59M | 2.62B | 2.75B |
Low Estimate | 611.40M | 642.00M | 2.59B | 2.69B |
Year ago Sales | 557.54M | 599.05M | 2.39B | 2.60B |
Year over Year Growth Est. | 11.54% | 8.33% | 8.78% | 4.66% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.09 | 0.14 | 0.57 | 0.63 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.09 | 0.15 | 0.61 | 0.73 |
Low Estimate | 0.09 | 0.11 | 0.53 | 0.54 |
Year ago EPS | 0.12 | 0.19 | 0.64 | 0.57 |
Year over Year Growth Est. | -25.00% | -26.32% | -10.94% | 9.94% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 2 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.09 | 0.14 | 0.57 | 0.63 |
7 Days Ago | 0.09 | 0.14 | 0.57 | 0.63 |
30 Days Ago | 0.09 | 0.14 | 0.57 | 0.63 |
60 Days Ago | 0.11 | 0.15 | 0.58 | 0.62 |
90 Days Ago | 0.11 | 0.15 | 0.57 | 0.62 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.09 | 0.14 | 0.57 | 0.63 |
Zacks Consensus Estimate | 0.09 | 0.14 | 0.57 | 0.63 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.14 | 0.19 | 0.19 | 0.12 | NA |
Estimate | 0.07 | 0.12 | 0.10 | 0.09 | NA |
Difference | 0.07 | 0.07 | 0.09 | 0.03 | 0.07 |
Surprise | 100.00% | 58.33% | 90.00% | 33.33% | 70.42% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more